Abstract Glucose-regulated protein 78 (GRP78) resides in endoplasmic reticulum (ER) and plays a role in protecting tumor cells against the toxic effects of anticancer agents. During the search for down-regulators of GRP78 using a reporter gene (luciferase) assay system, we isolated a novel compound designated as deoxyverrucosidin (1), a congener of verrucosidin (2), from Penicillium sp. and identified it as a down-regulator of the grp78 gene. The structure of 1 was determined by mainly ESI-mass and twodimensional NMR spectra. 1 dose-dependently inhibited the expression of GRP78 promoter with an IC 50 of 30 nM.
GRP78 resides in the endoplasmic reticulum (ER) and functions as a molecular chaperone by aiding the folding and transport of proteins it associates with transiently as they traverse the ER [1] [2] [3] . Strikingly, pathological conditions such as tumor growth correlate with GRP78 overexpression [4] . This could be partly caused by the activation of grp gene expression through glucose starvation, acidosis and hypoxia, which are hallmarks of the microenvironment of poorly vascularized solid tumors [5] . These correlations are supported by the observed increases in the levels of GRP78 expression in fibrosarcomas, in which GRP78 expression strongly correlates with tumor growth [6, 7] . The observation that GRP78 plays a role in protecting tumor cells against intracellular-mediated cytotoxicity and from the toxic effects of anticancer agents in vitro suggests that the induction of GRP78 may protect tumor cells in vivo [8] . Thus, substances that directly down-regulate GRP78 induction might be of potential use in cancer therapy.
During the course of our screening program for chaperone modulators using a reporter gene (luciferase) assay system, we have isolated a novel compound designated as deoxyverrucosidin (1) from Penicillium sp. and identified it as a down-regulator of the grp78 gene (Fig. 1) . In this paper, we report upon the isolation, structure elucidation and biological activities of 1. The producing strain Penicillium sp. was cultivated in a seed medium consisting of glucose 2%, yeast extract 0.2%, peptone 0.5%, MgSO 4 · 7H 2 O 0.05% and KH 2 PO 4 0.1% (pH 5.6) for 3 days at 28°C on a rotary shaker. The seed culture was transferred into a production medium composed of wheat bran -H 2 O (1 : 1) and fermentation was carried out in 500 ml flasks for 7 days at 28°C [9, 10] .
The mycelium obtained from 10 liters culture was extracted with acetone and the extract was concentrated in vacuo to eliminate acetone. The aqueous resultant was extracted with ethyl acetate. The organic layer was concentrated and applied to a column of silica gel eluted with hexane -ethyl acetate (10 : 1ϳ1 : 1). The active eluate was then chromatographed on a Sephadex LH-20 column eluted with MeOH. Finally, pure deoxyverrucosidin (1), a congener of verrucosidin (2), was obtained by HPLC using a YMC-pack ODS-A column (4.6 mm i.d. ϫ150 mm) eluted with 60% CH 3 CN [11] .
The UV spectra of Table 1 . A COSY experiment revealed two spin networks to generate partial structures A and B (Fig. 2) . The heteronuclear multiplebond correlation (HMBC) spectrum displayed 1 H- 
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Verrucosidin (Fig. 2) . By the process of elimination, two oxygenated carbons C-13 (d C 67.5) and C-14 (d C 67.4) should form an epoxide ring. Stereochemistry of tetrahydrofuran in 1 was proposed to be same as that of verrucosidin by identical chemical shift values and coupling constant of both compounds.
Biological activity of 1 and 2 were evaluated by reporter gene assay system utilizing luciferase gene. In brief, HT 1080 cells were transformed with luciferase gene under the control of grp78 promoter and the cells (20,000 in each well of 96-well plates) were incubated for 8 hours and treated for 18 hours with various concentrations of 1 or 2 in the presence or absence of the 2-DG. Firefly luciferase activity was determined using the luciferase assay kit. As expected, treatment with 2-DG resulted in a 4-fold increase of grp78 promoter activity in HT1080 cells. 1 and 2 dosedependently inhibited the expression of GRP78 promoter with IC 50 of 30 nM and 25 nM, respectively. These results indicate that 1 and 2 are specific inhibitors of the GRP78 promoter under low glucose conditions. Thus, it is hoped that these compounds are chemotherapeutically active against solid tumors, and/or that it can be used as a specific tool in studies addressing the molecular mechanisms of mammalian ER stress response. Detailed studies on biological activities are under the investigation. 
